VCCC
Join us for this inaugural VCCC event,?which aims to provide an update on what is new, challenging and controversial in the neoadjuvant management of patients with breast cancer.Hear from national experts?who will discuss and debate challenging multidisciplinary?aspects and Dr Eric Winer (Dana-Farber Cancer Institute), our international guest speaker, who will also give the?plenary lecture. The program will set the scene for the neoadjuvant patient and address dilemmas in surgical considerations, tumour heterogeneity, therapy sequencing, radiotherapy, reconstruction and supportive care. Challenging cases will be discussed by a multidisciplinary meeting (MDM) panel.Please join us at this event developed for practising clinicians and trainees across the breast cancer disciplines, including medical, surgical, radiation, nursing, pathology, radiology and psycho-oncology.PROGRAM TimeTopicSpeakers9- 9:30amRegistration9:30- 9:35amWelcomeBruce Mann Breast SurgeonSession 19:35-11amMultidisciplinary perspectives of neoadjuvant therapyCo-Chairs: Michelle White Bruce Mann Why all the talk about neoadjuvant therapy?Belinda Yeo Medical OncologistImplications of neoadjuvant therapy for the breast Caroline Baker Breast SurgeonCan a neoadjuvant approach actually improve survival outcomes? Prue Francis Medical OncologistRadiotherapy and reconstruction: sequencing optionsMichael ChaoRadiation OncologistDean TrotterPlastic Surgeon Discussion 11- 11:30amCoffee breakRegister today: (continued)TimeTopicSpeakersSession 211:30am-12:10pmSupportive care aspects of NATCo-Chairs:Heather BeanlandKathryn Wallace Supporting the neoadjuvant patient: are there special considerations?Lesley Stafford Clinical PsychologistWhat motivates a patient to choose NAT? Does treatment order matter?Kirsten Pilatti CEO Breast Cancer Network AustraliaFran BoyleMedical OncologistDiscussion Session 312:10- 1pmPathology, genomics and novel therapiesCo-Chairs:Stephen FoxGeoff LindemanWhat can we learn from the neoadjuvant approach about tumour heterogeneity?Sarah-Jane Dawson Medical OncologistUsing the neoadjuvant window to test novel therapiesSherene Loi Medical OncologistDiscussion 1- 1:45pmLunchSession 41:45-2:30pmPlenary LectureChair:Shom Goel“What have we done wrong with neoadjuvant therapy, and how are we going to fix it?” Eric WinerMedical Oncologist Session 52:30-3:50pmMDMChair:Belinda YeoChallenging case presentations by fellows/registrars with input from audience and MDM panelMDM Panel: Meron Pitcher Surgeon Allison Rose Radiologist Stephen Fox Pathologist Claire Phillips Radiation Oncologist Lisa Sheeran Nurse Consultant Richard de Boer Med Oncologist Fran Boyle Med Oncologist Dean Trotter Plastic surgeon 3:50-4pmClosing remarks and evaluation (networking & refreshments 4-5pm)Register today: ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.